Okay, I just selected English, so it should be working now.
I was just asking about the clinical trials, the impact of COVID-19 and whether or not you're seeing innovation within the system of going through phase one, phase two, and phase three, and whether you're seeing a more rapid system within the clinical trials without compromising, obviously, patient safety.